EYES News and Press, Second Sight Medical Products Inc. From 04/13/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Short-covering has become one of the hottest buzzwords of the year after Reddit forum, WallStreetBets, drove a monster rally in heavily shorted shares of Gamestop (NYSE: GME ) from $11 to $483 in days. “Risin...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips A couple days ago, hedge fund manager Will Meade came up with an interesting idea. He hopped on Twitter to discuss why he thinks ChargePoint (NYSE: CHPT ) could be the next GameStop (NYSE: GME ). The tweets ha...

Gainers: Scienjoy (SJ) +48%.Second Sight Medical Products (EYES) +36%.Greenwich LifeSciences (GLSI) +32%.Brooklyn ImmunoTherapeutics (BTX) +31%.Romeo Power (RMO) +28%.Target Hospitality (TH) +27%.BBQ Holdings (BBQ) +27%.SELLAS Life Sciences (SLS) +22%.GT Biopharma (GT...

Brooklyn Immuno Therapeutics (BTX) +77%.Scienjoy Holding (SJ) +37% on strategic alliance with Snipp.Weidai (WEI) +26%.Elite Education Group International (EEIQ) +16%.Phunware (PHUN) +12%. as board authorizes bitcoin purchases for Blockchain Ecosystem Launch.Romeo Power (RMO) +12% as...

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the “Company” or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced tha...

On Friday, Second Sight Medical Products (EYES) has notified its decision to terminate the memorandum of understanding (“MOU”) it has signed with Pixium Vision seeking a business combination.Calling the action by Second Sight Medical ‘unilateral and wrongful,&#x...

Second Sight Medical Products ([[EYES]] -1.8%) has named Scott Dunbar as its new acting chief executive officer replacing the former acting CEO Matthew Pfeffer who has stepped down on March 26.Scott Dunbar, Second Sight’s former senior patent counsel and compliance offic...

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced that the Company&...

The company develops retinal prosthesis systems, which visually remind me of the eyePhone from Futurama. Second Sight Medical Products is merging with a French sector player and its valuation stands at around $515 million. However, Second Sight ceased production activities in 2019...

Second Sight Medical Products, Inc. (NASDAQ: EYES) (the "Company" or “Second Sight”), a leading developer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced that it has close...